• United-Guardian Reports Second Quarter Financial Results

    来源: Nasdaq GlobeNewswire / 11 8月 2023 09:00:00   America/New_York

    HAUPPAUGE, N.Y., Aug. 11, 2023 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2023. Sales for the six-month period ended June 30th decreased from $7,518,535 in 2022 to $5,220,623 in 2023. Net income decreased from $1,544,789 ($0.34 per share) to $1,217,175 ($0.26 per share). Second quarter sales decreased from $3,626,177 to $2,650,299, with net income decreasing from $633,324 ($0.14 per share) to $461,094 ($0.10 per share).

    Donna Vigilante, President of United-Guardian, stated, “The sales decrease for both the second quarter and the first six months of 2023 was primarily due to a decrease in sales of our cosmetic ingredients, which was partially offset by an increase in sales of Renacidin®, the Company’s principal pharmaceutical product, which increased by 7%. The distributor responsible for marketing our Lubrajel® line of cosmetic ingredients in China experienced decreased demand due to increased competition in China from lower-priced competitive products, especially those from Asian producers, along with slow post-COVID economic recovery in China. In addition, customers are maintaining lower inventory levels and changing to just-in-time inventory management, which negatively impacted our sales. We are evaluating various options to increase our sales both in China and in other markets, and are continuing to work closely with our marketing partners to develop new strategies to remain competitive while growing our market share. We are hopeful that these efforts, along with China’s re-opening progress, will result in an increase in sales going forward.”

    United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, and medical lubricants.

     Contact:Donna Vigilante
      (631) 273-0900
      dvigilante@u-g.com


    NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.


    Financial Results for the
    Three and Six Months Ended
    June 30, 2023 and 2022

    STATEMENTS OF INCOME
    (unaudited)

       THREE MONTHS
    ENDED JUNE 30,
      SIX MONTHS ENDED
    JUNE 30,
      2023  2022  2023  2022 
                 
    Net sales$2,650,299 $3,626,177 $5,220,623 $7,518,535 
                 
    Costs and expenses:            
    Cost of sales 1,429,407  1,693,753  2,523,002  3,403,870 
    Operating expenses 574,093  620,229  1,092,039  1,166,978 
    Research and development expense  128,729   112,266   255,688   243,932 
    Total costs and expenses 2,132,229  2,426,248  3,870,729  4,814,780 
         Income from operations  518,070  1,199,929  1,349,894  2,703,755 
                 
    Other income (expense):            
    Investment income 54,950  58,860  102,582  99,410 
    Net gain (loss) gain on marketable securities  7,479   (460,278)  80,180   (853,938)
    Total other income (expense)   62,429   (401,418)  182,762   (754,528)
         Income before provision for income taxes 580,499  798,511  1,532,656  1,949,227 
                 
    Provision for income taxes  119,405   165,187   315,481   404,438 
                        Net income$ 461,094 $ 633,324 $1,217,175 $1,544,789 
                 
    Earnings per common share            
    (basic and diluted)$0.10 $0.14 $0.26 $0.34 
                 
    Weighted average shares            
    (basic and diluted) 4,594,319  4,594,319  4,594,319  4,594,319 


    Additional financial information can be found on the company’s web site at www.u-g.com.


分享